Journal article

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, KB Zarnke, K Nerenberg, KC Harris, M Nakhla, L Cloutier, M Gelfer, M Lamarre-Cliche, A Milot, P Bolli, G Tremblay, D McLean, SW Tobe, M Ruzicka, KD Burns, M Vallée Show all

Canadian Journal of Cardiology | ELSEVIER SCIENCE INC | Published : 2017

Abstract

Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension. This year, we introduce 10 new guidelines. Three previous guidelines have been revised and 5 have been removed. Previous age and frailty distinctions have been removed as considerations for when to initiate antihypertensive therapy. In the presence of macrovascular target organ damage, or in those with independent cardiovascular risk factors, antihypertensive therapy should be considered for all individuals with elevated average systolic nonautomated office blood pressure (non-AOBP) readings ≥ 140 mm Hg. For individuals with diastolic hypertension..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

Activities of the HCGC are supported by Hypertension Canada. The members of the HCGC are unpaid volunteers who contribute their time and expertise to the annual development and dissemination of the Hypertension Canada guidelines. To maintain professional credibility of the content, the process for the development of the guidelines is fully independent and free from external influence. External partners assist with the dissemination of the approved guidelines.